HYDROCORTISONE ACETATE AND PRAMOXINE HYD

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55), a certified small business, for the purchase of two units of hydrocortisone acetate and pramoxine hydrochloride (NDC 45802-0144-64) at a total contract value of $247.48. The order, issued on August 2, 2026, with a required delivery date of August 3, 2026, is FOB destination, meaning the contractor assumes all transportation costs and risks until the goods are received at the USS ZUMWALT (DDG 1000), FPO AP 96693. The product must be shipped via the fastest traceable means, excluding parcel post, and all packaging must be clearly marked with the contract number, part number, and CAGE code, though no specific packaging materials, environmental controls, or barcoding standards are mandated. The contract operates under FAR Part 12 as a commercial item acquisition, incorporating clauses 52.212-3, 52.212-4, and 52.212-5 by reference, with the small business status affirmed but no other socioeconomic certifications claimed. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using payment code SL4701, with invoices likely submitted via electronic data interchange. Inspection and acceptance occur at the delivery point by an authorized government representative, and compliance with DLA procurement policies and unit-of-issue standards is required, though no MIL-STD or formal quality specifications are cited. Contract oversight is managed by DLA Troop Support’s Medical Supply Chain FSB, with designated administrative contacts provided. The award was processed as a streamlined RFQ under an indefinite-delivery contract structure, with no options, price variations, or evaluation factors disclosed in the documentation.